Blueprint Medicines shares owned by Woodline Partners
Quarter-by-quarter ownership of Blueprint Medicines (BPMC) shares owned by Woodline Partners
from 13F filings
Historical chart of Woodline Partners investment in Blueprint Medicines
Tip: Access up to 7 years of quarterly data
All positions including Blueprint Medicines held by Woodline Partners consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Blueprint Medicines by Woodline Partners
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $42M | 454k | 92.50 |
| 2024-06-30 | $95M | 880k | 107.78 |
| 2024-03-31 | $79M | 827k | 94.86 |
| 2023-09-30 | $30M | 602k | 50.22 |
| 2023-06-30 | $18M | 291k | 63.20 |
| 2023-03-31 | $4.7M | 105k | 44.99 |
| 2022-12-31 | $11M | 241k | 43.81 |
| 2022-09-30 | $6.2M | 93k | 65.89 |
| 2022-06-30 | $5.9M | 116k | 50.51 |
| 2022-03-31 | $1.6M | 25k | 63.88 |
| 2021-12-31 | $6.6M | 62k | 107.11 |
| 2021-09-30 | $18M | 172k | 102.81 |
| 2021-06-30 | $5.0M | 57k | 87.97 |
| 2021-03-31 | $8.6M | 89k | 97.23 |